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Unfortunately, the original version of this article [1]
contained an error. Within Fig. 1, Fig. 1c and d were
missing. The correct version of Fig. 1 can be found
below and has been updated in the original article.
Author details
1Lung Cancer Branch, Research Institute, National Cancer Center, Goyang,
Korea. 2PANAGENE Inc., Daejeon, Korea. 3Center for Lung Cancer, Hospital,
National Cancer Center, 323 Ilsan-ro, Ilsan-dong-gu, Goyang, Gyeonggi
10408, Korea.
Received: 5 September 2016 Accepted: 5 September 2016
Reference
1. Han JY, et al. PNA clamping-assisted fluorescence melting curve analysis for
detecting EGFR and KRAS mutations in the circulating tumor DNA of patients
with advanced non-small cell lung cancer. BMC Cancer. 2016;16:627.
doi:10.1186/s12885-016-2678-2.* Correspondence: jymama@ncc.re.kr
1Lung Cancer Branch, Research Institute, National Cancer Center, Goyang,
Korea
3Center for Lung Cancer, Hospital, National Cancer Center, 323 Ilsan-ro,
Ilsan-dong-gu, Goyang, Gyeonggi 10408, Korea
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver




Fig. 1 Schematic representation of EGFR and KRAS mutation
detection using PANAMutyperTM: EGFR (a) and KRAS (b). Sensitivity
of the EGFR L858R and E19del (c) and KRAS G12V and G12R (d)
mutants according to their cellularity by diluting to 100, 10, 1, 0.1,
0.01, 0 % with respect to the wild cell line DNA and mutant cell line
DNA. The data presented here are representative obtained from
sensitivity test conducted more than 50 times. MT, mutant type
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